Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$2.99 USD
-0.03 (-0.99%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $2.98 -0.01 (-0.33%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For OVID
-
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
-
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
-
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
-
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
-
Ovid Therapeutics (OVID) Reports Q2 Loss, Lags Revenue Estimates
-
Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
-
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
-
Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
-
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results
-
Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
-
Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights